Application of oxymatrine in reducing epidermal cell death caused by lipotoxicity of psoriasis patient
A technology of oxymatrine and epidermal cells, applied in the field of medicine, can solve the problems of poorly understood metabolic changes of psoriasis
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment Construction
[0032] The application of oxymatrine in reducing epidermal cell death caused by lipotoxicity in patients with psoriasis comprises the following steps:
[0033] (2) Collection of patient information
[0034] From December 2018 to May 2019, the inventor recruited 32 patients and 29 healthy volunteers who were clinically or histologically diagnosed with severe plaque psoriasis in the Outpatient Department of Ningxia Medical University General Hospital. All patients were administered Tianqing Fuxin (oxymatrine >98%, 0.6g (100mL) / d) according to the clinical trial registration guidelines of China Jiangsu Jiatai Tianqing Pharmaceutical Group Co., Ltd. (CHICCTR-TRc-14004301). 8 weeks in total. The severity of psoriasis patients was quantified using the Psoriasis Area and Severity Index (PASI) score, Psoriasis Global Assessment (PGA) score, and Body Surface Area (BSA) score. In addition, the Dermatology Life Quality Index (DLQI) questionnaire was used to measure how much skin proble...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com